Evidence map›Paper›PMID 26489457›Full record

ArticleCell reports2015

Prolyl Isomerase Pin1 Regulates Axon Guidance by Stabilizing CRMP2A Selectively in Distal Axons.

Martin Balastik, Xiao Zhen Zhou, Meritxell Alberich-Jorda, Romana Weissova, Jakub Žiak, Maria F Pazyra-Murphy, Katharina E Cosker, Olga Machonova, Iryna Kozmikova, Chun-Hau Chen and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 4 countries.

Martin BalastikDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, CLS 0408, Boston, MA 02215, USA; Institute of Molecular Genetics, Vídeňská 1083, 142 20 Prague 4, Czech Republic; Institute of Physiology, Vídeňská 1083, 142 20 Prague 4, Czech Republic. Electronic address: martin.balastik@fgu.cas.cz.
Xiao Zhen ZhouDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, CLS 0408, Boston, MA 02215, USA.
Meritxell Alberich-JordaDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, CLS 0408, Boston, MA 02215, USA; Institute of Molecular Genetics, Vídeňská 1083, 142 20 Prague 4, Czech Republic.
Romana WeissovaInstitute of Molecular Genetics, Vídeňská 1083, 142 20 Prague 4, Czech Republic; Institute of Physiology, Vídeňská 1083, 142 20 Prague 4, Czech Republic.
Jakub ŽiakInstitute of Molecular Genetics, Vídeňská 1083, 142 20 Prague 4, Czech Republic; Institute of Physiology, Vídeňská 1083, 142 20 Prague 4, Czech Republic.
Maria F Pazyra-MurphyDepartment of Pediatric Oncology and Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
Katharina E CoskerDepartment of Pediatric Oncology and Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
Olga MachonovaInstitute of Molecular Genetics, Vídeňská 1083, 142 20 Prague 4, Czech Republic.
Iryna KozmikovaInstitute of Molecular Genetics, Vídeňská 1083, 142 20 Prague 4, Czech Republic.
Chun-Hau ChenDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, CLS 0408, Boston, MA 02215, USA.
Lucia PastorinoDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, CLS 0408, Boston, MA 02215, USA.
John M AsaraDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, CLS 0408, Boston, MA 02215, USA.
Adam ColeBiomedical Research Institute, University of Dundee, Ninewells Hospital, Dundee DD1 9SY, Scotland, UK.
Calum SutherlandBiomedical Research Institute, University of Dundee, Ninewells Hospital, Dundee DD1 9SY, Scotland, UK.
Rosalind A SegalDepartment of Pediatric Oncology and Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
Kun Ping LuDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, CLS 0408, Boston, MA 02215, USA; Institute for Translational Medicine, Fujian Medical University, Fuzhou 350108, China. Electronic address: klu@bidmc.harvard.edu.
Harvard University · USCzech Academy of Sciences, Institute of Molecular Genetics · CZBeth Israel Deaconess Medical Center · USNinewells Hospital · GBCzech Academy of Sciences, Institute of Physiology · CZ

Funding

Spatial Considerations in Neuronal Survival SignalsR01NS050674 · NINDS · DANA-FARBER CANCER INSTITUTE · PI SEGAL, ROSALIND A. · 2005 to 2021
$5.9M
Role of the Prolyl Isomerase Pin1 in the Development and Treatment of AsthmaR01HL111430 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LU, KUN PING · 2012 to 2015
$2.7M
Drug Discovery against the Early, Secreted and Toxic Tau in Alzheimer's DiseaseR01AG046319 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LU, KUN PING · 2014 to 2018
$1.8M
Pin1-Catalyzed Protein Conformational Regulation in Alzheimer's DiseaseR01AG039405 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LU, KUN PING · 2011 to 2015
$1.8M
CONFOCAL MICROSCOPE: SURGICAL DISEASES, WOUND HEALINGS10RR017927 · NCRR · BETH ISRAEL DEACONESS MEDICAL CENTER · PI HAGEN, SUSAN J · 2006 to 2006
$427k
Biotechnology and Biological Sciences Research Council C18727NCRR NIH HHS S10 RR017927NHLBI NIH HHS R01 HL111430NIA NIH HHS R01 AG039405NIA NIH HHS R01AG039405NIA NIH HHS R01 AG046319NIA NIH HHS R01AG046319NINDS NIH HHS R01 NS050674
6 · The paper itself

Abstract

Axon guidance relies on precise translation of extracellular signal gradients into local changes in cytoskeletal dynamics, but the molecular mechanisms regulating dose-dependent responses of growth cones are still poorly understood. Here, we show that during embryonic development in growing axons, a low level of Semaphorin3A stimulation is buffered by the prolyl isomerase Pin1. We demonstrate that Pin1 stabilizes CDK5-phosphorylated CRMP2A, the major isoform of CRMP2 in distal axons. Consequently, Pin1 knockdown or knockout reduces CRMP2A levels specifically in distal axons and inhibits axon growth, which can be fully rescued by Pin1 or CRMP2A expression. Moreover, Pin1 knockdown or knockout increases sensitivity to Sema3A-induced growth cone collapse in vitro and in vivo, leading to developmental abnormalities in axon guidance. These results identify an important isoform-specific function and regulation of CRMP2A in controlling axon growth and uncover Pin1-catalyzed prolyl isomerization as a regulatory mechanism in axon guidance.

Indexed as

AnimalsAxonsCell Line, TumorFemaleHumansImmunohistochemistryImmunoprecipitationMaleNerve Tissue ProteinsNIMA-Interacting Peptidylprolyl IsomerasePeptidylprolyl IsomerasePhosphorylationSignal TransductionZebrafishZebrafish Proteinsdpysl2b protein, zebrafishNerve Tissue ProteinsNIMA-Interacting Peptidylprolyl IsomerasePeptidylprolyl IsomerasePIN1 protein, humanZebrafish Proteins

Identifiers

PMID26489457
PMCPMC4662601
OpenAlexW2119582763

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.